Zimmer Biomet Holdings Inc at Bank of America Global Healthcare Conference Transcript
Good morning, everybody. Travis Steed, medical device analyst at BofA. And next up, we have Zimmer Biomet. We got the full team up here, Bryan, Suky and Ivan. So thanks for coming, and welcome.
Thanks for having us. Great.
Questions & Answers
I was thinking to break the conversation up kind of 3 pieces. We'll talk kind of Q1, Q2, more near-term trends. And then kind of move to the second bucket, more of the longer-term structural growth drivers for ortho, and how some of that potentially could be structurally different?
And then maybe M&A is kind of the longer-term transition for Zimmer Biomet. So that's how we think about breaking the conversation up. And then so for some of the Q1 stuff, it seems like there was a lot of moving parts in Q1. There was a comp benefit. There was an easier staffing
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |